Posterior Segment Toxicity After Gemcitabine and Docetaxel Chemotherapy

Optometry and Vision Science - United States
doi 10.1097/opx.0000000000000571
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Triplet Chemotherapy Combination With Cisplatin, Gemcitabine and Docetaxel in Patients With Chemotherapy‑naive Advanced Non-Small Cell Lung Cancer

Oncology Letters
Cancer ResearchOncology
2013English

Clinical Observation of Docetaxel or Gemcitabine Combined With Cisplatin in the Chemotherapy After Surgery for Stage II-III Non-Small Cell Lung Cancer

West Indian Medical Journal
Medicine
2015English

Gemcitabine and Docetaxel Combination Chemotherapy for Advanced Bone and Soft Tissue Sarcomas: Protocol for an Open-Label, Non-Randomised, Phase 2 Study

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Lung Fibrosis After Chemotherapy Containing Docetaxel in a Patient Treated for Breast Cancer

International Journal of Cancer Studies & Research
2015English

Outcome of Combination Chemotherapy With Docetaxel, Estramustine Phosphate, and Carboplatin After Docetaxel and Prednisolone Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer

Journal of Cancer Therapy
2016English

Sarcopenia and Chemotherapy-Mediated Toxicity

Einstein (São Paulo, Brazil)
Medicine
2016English

Timing of Chemotherapy-Induced Neutropenia: The Prognostic Factor in Advanced Pancreatic Cancer Patients Treated With Gemcitabine / Gemcitabine-Based Chemotherapy

Oncotarget
Oncology
2017English

Docetaxel as Second Line After Failure of Gemcitabine/Cisplatin Regimen in Advanced and/or Metastatic Urinary Bladder Cancer Patients in Egypt

Research in Oncology
2013English

Cabazitaxel in the Management of Metastatic Castration-Resistant Prostate Cancer Progressing After Docetaxel-Based Chemotherapy

European Oncology and Haematology
OncologyHematology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy